Evidence map›Paper›PMID 37386568›Full record

ArticlePediatric rheumatology online journal2023

Kawasaki disease (KD) and multisystem inflammatory syndrome in children (MIS-C) in a Middle Eastern patient cohort.

Lemis Yavuz, Sarmad AlHamdani, Samah Alasrawi, Deena Wafadari, Ali Al-Fraihat, Marwa A Bebars, Jaidev Nath, Diego Arango, Marco Pallavidino, Ruchi Jain and 5 more

Abstract readComparative Study
In one paragraph

Article in Pediatric rheumatology online journal, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Children (Basel, Switzerland) · 2024
    Article
  5. Article
  6. Article
  7. Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Lemis YavuzAl Jalila General Pediatric Department, Al Jalila Children's Hospital, Dubai, United Arab Emirates. osmanlames@hotmail.com.ORCID http://orcid.org/0000-0002-1970-6930
Sarmad AlHamdaniAl Jalila General Pediatric Department, Al Jalila Children's Hospital, Dubai, United Arab Emirates.
Samah AlasrawiAl Jalila Children's Heart Center of excellence, Al Jalila Children's Hospital, Dubai, United Arab Emirates.
Deena WafadariAl Jalila General Pediatric Department, Al Jalila Children's Hospital, Dubai, United Arab Emirates.
Ali Al-FraihatAl Jalila Residency Program, Al Jalila Children's Hospital, Dubai, United Arab Emirates.
Marwa A BebarsPediatric Department, Dubai Hospital, Dubai, United Arab Emirates.
Jaidev NathAl Jalila General Pediatric Department, Al Jalila Children's Hospital, Dubai, United Arab Emirates.
Diego ArangoAl Jalila Pediatric Intensive Care Unit, Al Jalila Children's Hospital, Dubai, United Arab Emirates.
Marco PallavidinoAl Jalila Pediatric Intensive Care Unit, Al Jalila Children's Hospital, Dubai, United Arab Emirates.
Ruchi JainAl Jalila Genomics Center, Al Jalila Children's Hospital, Dubai, United Arab Emirates.
Sinan YavuzAl Qasimi General Pediatric Department, Al Qasimi Women and Children's Hospital, Sharjah, United Arab Emirates.
Mohamed AlAwadhiAl Jalila General Pediatric Department, Al Jalila Children's Hospital, Dubai, United Arab Emirates.
Abdulla AlkhayatAl Jalila General Pediatric Department, Al Jalila Children's Hospital, Dubai, United Arab Emirates.
Ahmad Abou TayounAl Jalila Genomics Center, Al Jalila Children's Hospital, Dubai, United Arab Emirates.
Walid Mohammad AbuhammourAl Jalila Infectious Disease Department, Al Jalila Children's Hospital, Dubai, United Arab Emirates.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveThis is a comprehensive characteristic study of Kawasaki disease (KD) and Multi system inflammatory syndrome in children (MIS-C) in the Middle East that creates a formula to differentiate between the two.

methodsWe conducted a descriptive comparative study of KD and MIS-C in the United Arab Emirates. Retrospective MIS-C and KD cohorts were recruited between January 2017 until August 2021.We compared clinical and laboratory characteristics between both groups. Our data were compared with 87 patients with KD or MIS-C from the literature.

resultsWe report on123 patients. Sixty-seven (54%) met the criteria for KD (36 male, 43 Arab), and fifty-six (46%) met the criteria for MIS-C (28 male, 35 Arab). The median age was 2.2 years range (0.15-10.7) in the KD group and 7.3 years (0.7-15.2) in the MIS-C group (P < 0.001). The clinical features on admission showed an increase in gastrointestinal manifestations in MIS-C compared with KD (84% vs. 31%, P < 0.001). Laboratory tests on admission revealed a significant increase in the following tests in KD compared with MIS-C; white blood cells (mean 16.30 10

conclusionThis study showed vast similarities between KD and MIS-C, suggesting that they lie along the same clinical spectrum. However, there are several differences between the two disease entities suggesting that MIS-C most likely represents a new severe variant of KD. Based on our findings in this study, we created a formula to differentiate between KD and MIS-C.

Indexed as

Mucocutaneous Lymph Node SyndromeAdolescentChildChild, PreschoolCOVID-19Diagnosis, DifferentialFemaleHumansInfantMaleMiddle Eastern PeopleRetrospective StudiesSystemic Inflammatory Response SyndromeUnited Arab EmiratesCOVID-19Fever in childrenInflammatory diseaseKDMIS-CPediatrics

Identifiers

PMID37386568
PMCPMC10308603

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.